MANUEL ALEJANDRO ROMERO MARTÍNEZ-rekin lankidetzan egindako argitalpenak (23)

2017

  1. Corrigendum: Melatonin and nitrones as potential therapeutic agents for stroke [Front. Aging Neurosci., 8 (2016) (281)] DOI:10.3389/fnagi.2016.00281

    Frontiers in Aging Neuroscience

2016

  1. Melatonin and nitrones as potential therapeutic agents for stroke

    Frontiers in Aging Neuroscience, Vol. 8, Núm. NOV

2015

  1. Both creatine and its product phosphocreatine reduce oxidative stress and afford neuroprotection in an in vitro Parkinson’s model

    ASN Neuro, Vol. 6, Núm. 6

2014

  1. ITH12410/SC058: A new neuroprotective compound with potential in the treatment of Alzheimer's disease

    ACS Chemical Neuroscience, Vol. 5, Núm. 9, pp. 770-775

  2. Toxicological and pharmacological evaluation, antioxidant, ADMET and molecular modeling of selected racemic chromenotacrines {11-amino-12-aryl-8,9, 10,12-tetrahydro-7H-chromeno[2,3-b]quinolin-3-ols} for the potential prevention and treatment of Alzheimer's disease

    European Journal of Medicinal Chemistry, Vol. 74, pp. 491-501

2013

  1. Nontoxic and neuroprotective β-naphthotacrines for alzheimer's disease

    Chemical Research in Toxicology, Vol. 26, Núm. 6, pp. 986-992

  2. Novel tacrine-related drugs as potential candidates for the treatment of Alzheimer's disease

    Bioorganic and Medicinal Chemistry Letters, Vol. 23, Núm. 7, pp. 1916-1922

  3. Protective effect of creatine against 6-hydroxydopamine-induced cell death in human neuroblastoma SH-SY5Y cells: Involvement of intracellular signaling pathways

    Neuroscience, Vol. 238, pp. 185-194

2012

  1. Galantamine elicits neuroprotection by inhibiting iNOS, NADPH oxidase and ROS in hippocampal slices stressed with anoxia/reoxygenation

    Neuropharmacology, Vol. 62, Núm. 2, pp. 1082-1090

  2. Guanosine protects human neuroblastoma SH-SY5Y cells against mitochondrial oxidative stress by inducing heme oxigenase-1 via PI3K/Akt/GSK-3β pathway

    Neurochemistry International, Vol. 61, Núm. 3, pp. 397-404

  3. Synthesis, biological assessment, and molecular modeling of racemic 7-aryl-9,10,11,12-tetrahydro-7H-benzo[7,8]chromeno[2,3-b]quinolin-8-amines as potential drugs for the treatment of Alzheimer's disease

    European Journal of Medicinal Chemistry, Vol. 54, pp. 750-763

2011

  1. Cholinergic and neuroprotective drugs for the treatment of Alzheimer and neuronal vascular diseases. II. Synthesis, biological assessment, and molecular modelling of new tacrine analogues from highly substituted 2-aminopyridine-3- carbonitriles

    Bioorganic and Medicinal Chemistry, Vol. 19, Núm. 1, pp. 122-133

  2. N-Acylaminophenothiazines: Neuroprotective agents displaying multifunctional activities for a potential treatment of Alzheimer's disease

    European Journal of Medicinal Chemistry, Vol. 46, Núm. 6, pp. 2224-2235

  3. Neuroprotective effect of guanosine against glutamate-induced cell death in rat hippocampal slices is mediated by the phosphatidylinositol-3 kinase/Akt/ glycogen synthase kinase 3β pathway activation and inducible nitric oxide synthase inhibition

    Journal of Neuroscience Research, Vol. 89, Núm. 9, pp. 1400-1408

  4. Neurotoxicity induced by dexamethasone in the human neuroblastoma SH-SY5Y cell line can be prevented by folic acid

    Neuroscience, Vol. 190, pp. 346-353

  5. Neurotoxicity induced by okadaic acid in the human neuroblastoma SH-SY5Y line can be differentially prevented by α7 and β2* nicotinic stimulation

    Toxicological Sciences, Vol. 123, Núm. 1, pp. 193-205

2005

  1. Toxic effects of cadmium on GABA and taurine content in different brain areas of adult male rats

    Journal of Physiology and Biochemistry, Vol. 61, Núm. 3, pp. 439-446

  2. Toxic effects of cadmium on the regulatory mechanism of dopamine and serotonin on prolactin secretion in adult male rats

    Toxicology Letters, Vol. 155, Núm. 1, pp. 87-96

2004

  1. Cadmium exposure differentially modifies the circadian patterns of norepinephrine at the median eminence and plasma LH, FSH and testosterone levels

    Toxicology Letters, Vol. 146, Núm. 2, pp. 175-182

  2. Effect of nitric oxide on prolactin secretion and hypothalamic biogenic amine contents

    Life Sciences, Vol. 74, Núm. 13, pp. 1681-1690